
Negative impacts of the administration of hydroxycloroquine and anticoagulant in patients with SARS-COV-2 infection: a randomized clinical trial
Author(s) -
Matheus Henrique Fernandes,
Matheus Rodrigues de Oliveira,
Alfredo Herbert Zielke Filho,
Clóvis José Torres Gomes,
Lucyara Martins Oliveira,
Frederico Palumbo Araújo,
Sofia Mirela Schreier Rodrigues,
Karine Paiva de Andrade,
Ana Clara Beraldo Muniz,
Gabriel Prado Leão Teixeira,
Guilherme Tadeu Tucci Castilho,
Mariana Gazzinelli Maiolini,
Camilla Kallás Hueb,
Elisa Rosa Silva,
Paula Fernanda Correa,
Marcella Nora Maia,
Maria Eugênia Sousa Magalhães,
Laís Boczar Dias,
Pedro Augusto Schreier Rodrigues,
José Renato de Melo,
Breno César Diniz Pontes,
Paulo Roberto Maia,
Sérgio Rodrigo Beraldo,
José Dias da Silva Neto
Publication year - 2022
Publication title -
revista de medicina
Language(s) - English
Resource type - Journals
eISSN - 1679-9836
pISSN - 0034-8554
DOI - 10.11606/issn.1679-9836.v101i4e-187545
Subject(s) - medicine , hydroxychloroquine , anticoagulant , apixaban , randomized controlled trial , clinical trial , placebo , covid-19 , atrial fibrillation , alternative medicine , warfarin , rivaroxaban , disease , pathology , infectious disease (medical specialty)